Table 1.
CFDC MICs (mg/L) | |||
---|---|---|---|
Strain | LB | HPF | 3.5% HSA |
AB5075 | 0.5 (S) | 1 (S) | 2 (S) |
ABUH702 | 0.38 (S) | 1.5 (S) | 3 (S) |
AMA16 | >4.5 * (I) | >256 (R) | 32 * (R) |
AB0057 | 1 (S) | 8 (I) | 1.5 (S) |
AMA40 | 0.5 (S) | 16 * (R) | 3 (S) |
AMA41 | 0.094 (S) | 0.5–0.75 (S) | 2 (S) |
AMA113 | 0.5 (S) | 1.5 (S) | 1.5 (S) |
AMA181 | 0.19 (S) | 0.19 (S) | 0.75 (S) |
AMA3 | 24 (R) | >256 (R) | 32 * (R) |
AMA4 | 16 * (R) | 48 * (R) | 64 * (R) |
AMA5 | >256 (R) | >256 (R) | 16 * (R) |
AMA9 | 32 (R) | 48 (R) | 16 (R) |
AMA14 | 8 * (I) | 16 * (R) | 12 (I) |
AMA17 | >256 (R) | >256 (R) | >256 (R) |
AMA18 | 64 * (R) | 16 * (R) | 16 * (R) |
AMA19 | 4 (S) | 4 (S) | 48 * (R) |
AMA28 | 32 * (R) | >256 (R) | 32 * (R) |
AMA30 | 64 * (R) | 128 * (R) | 12 * (I) |
AMA31 | >256 (R) | >256 (R) | 96 * (R) |
AMA33 | 16 * (R) | >256 (R) | >256 (R) |
* Intra-colonies are present. S: Susceptible, I: Intermediate, R: Resistant.